J&J unit begins clinical trial of Incraft stent

04/13/2010 | Clinica (subscription required)

Johnson & Johnson's Cordis unit has begun a nonrandomized trial designed to test the ability of its Incraft stent in treating patients with abdominal aortic aneurysm. The device features an ultra-low-profile delivery system and can be tailored to an individual patient during implantation.

View Full Article in:

Clinica (subscription required)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Director of ASO Department
Bluegrass Family Health
Lexington-or could be in Nashville, TN, KY
Claims Director
PacificSource
Springfield, OR
Mgr NGS Provider Enrollment (I)
National Government Services - WellPoint
Harrisburg, PA
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA